SR One Capital Management
Status
ACTIVE
Global HQ
Seattle, United States
Countries of investment
- Israel
- USA
- Canada
- India
Investment stages
- Seed
Industries
- Health Tech
- PropTech
About
SR One is a biotech venture capital firm translating innovative science into medicines, focusing on strong fundamentals and novel approaches to disease treatment.
SR One is a biotech venture capital firm translating innovative science into medicines, focusing on strong fundamentals and novel approaches to disease treatment.
Investment Thesis
SR One takes a backandbuild approach to its investments, focusing on companies with strong underlying fundamentals, a clearly defined development pathway, and novel approaches to addressing diseases.
Manager's Experience
With a robust background in private equity, the fund manager has successfully executed over 30 deals across the technology and healthcare sectors. Active primarily in North America and Europe, their strategic approach emphasizes an operator-first style, leveraging operational expertise to drive value creation. Notable exits include several high-growth companies that have significantly outperformed market expectations, underscoring a data-driven investment thesis. Their experience spans various stages of investment, from growth capital to late-stage buyouts, showcasing a versatility that enhances portfolio resilience.
Team
Vikas Goyal
Simeon George
Rajeev Dadoo
Rajeev Dadoo
Philip Smith
Michael Diem
Karen Engel
Jill Carroll
James Macadam
Deborah Harland